APP and Alzheimer disease: In a nutshell, current study suggests beneficial therapeutic role of H2S in AD as it interferes with HENECA stimulated Aβ42 production by attenuating APP maturation and inhibiting γ-secretase via a cAMP dependent pathway (Fig 9).